Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The objective of this study was to assess the efficacy and safety of amitriptyline as a treatment of FM. A comprehensive computerized search in Medline (Pubmed), EMBASE and The Cochrane Library was performed. Randomized controlled trials (RCTs) comparing amitriptyline vs placebo in adult patients suffering from FM were identified, the methodological quality was assessed and the results of the main outcomes were evaluated. Ten RCTs were identified. Large clinical variability and statistical heterogeneity precluded quantitative meta-analysis. Overall, the study quality was moderate to high. Amitriptyline 25 mg/day (six RCTs) demonstrated a therapeutic response compared with placebo in the domains of pain, sleep, fatigue and overall patient and investigator impression. This benefit was generally seen at 6-8 weeks of treatment but no effect was noted at 12 weeks. Amitriptyline 50 mg/day (four RCTs) did not demonstrate a therapeutic effect compared with placebo. Neither dose of amitriptyline had an effect on tender points count. No clear statements on adverse events with amitriptyline can be made due to inconsistencies in data among the studies. A definitive clinical recommendation regarding the efficacy of amitriptyline for FM symptoms cannot be made. There is some evidence to support the short-term efficacy of amitriptyline 25 mg/day in FM. There is no evidence to support the efficacy of amitriptyline at higher doses or for periods >8 weeks. More stringent RCTs with longer follow-up periods are required to determine the long-term efficacy and safety of the amitriptyline and define its role in the multidisciplinary management of FM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A., & Feigenbaum, S. L. (1981) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(81)90096-2 · Cited by 910
Bennett, R. M., Kamin, M., Karim, R., & Rosenthal, N. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00116-5 · Cited by 403
Treatment of fibromyalgia with antidepressants: A meta-analysis
O’Malley, P. G., Balden, E., Tomkins, G., Santoro, J., Kroenke, K., & Jackson, J. L. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.06279.x · Cited by 340
Hannonen, P. (1998) · Rheumatology · doi:10.1093/rheumatology/37.12.1279 · Cited by 133
Cited by
EULAR revised recommendations for the management of fibromyalgia
Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Fluß, E., Choy, E., Kosek, E., Amris, K., Branco, J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209724 · Cited by 1,566
Lee, Y. C., Nassikas, N. J., & Clauw, D. J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3306 · Cited by 377
“Ten randomized, double-blinded, placebo-controlled trials have examined the effi cacy of amitriptyline in fi bromyalgia [ 68 ].”
BackgroundManagement of functional somatic syndromes and bodily distress
Henningsen, P., Zipfel, S., Sattel, H., & Creed, F. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000484413 · Cited by 335
Hauser, W., Petzke, F., Uceyler, N., & Sommer, C. (2011) · Rheumatology · doi:10.1093/rheumatology/keq354 · Cited by 290
Beyond pain in fibromyalgia: Insights into the symptom of fatigue
Vincent, A., Benzo, R. P., Whipple, M. O., McAllister, S. J., Erwin, P. J., & Saligan, L. N. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4395 · Cited by 133
“1 open RCT (n = 78) of patients with FM [116] VAS fatigue 2 meta-analyses found improvement, but MCID cannot be determined 2 meta-analyses of 10 RCTs (n = 615) [121] and 13 RCTs [122] in patients with FM”
Background
Metadata
- Authors
- Nishishinya, B., Urrutia, G., Walitt, B., Rodriguez, A., Bonfill, X., Alegre, C., & Darko, G.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-14
- Volume
- 47
- Issue
- 12
- Pages
- 1741-1746
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2169086521
- Cited by
- 96
- References
- 5
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. https://app.cochat.ai/papers/10.1093/rheumatology/ken317
- The paper
- Nishishinya, B., Urrutia, G., Walitt, B., Rodriguez, A., Bonfill, X., Alegre, C., & Darko, G. (2008). Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology. https://doi.org/10.1093/rheumatology/ken317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.